Dr. Gurpreet Lamba specializes in hematology and oncology, and is board certified in hematology and clinical oncology. Dr. Lamba recently moved to the New Jersey area from Vermont where he was an attending physician in hematology and oncology at the University of Vermont Medical Center. Dr. Lamba was actively involved in clinical and translational research for treatment options and supportive care for patients with leukemia, lymphomas and other hematologic malignancies. Dr. Lamba also participated in numerous national cooperative group and industry trials. He was involved in the design and conduct of Phase I, II and III clinical trials.
Dr. Lamba received his medical degree from Jawaharlal Nehru Medical College, Belgaum, India. He completed his residency at New York Medical College at Westchester Medical Center, Valhalla, NY in Internal Medicine and conducted his fellowship training at New York Medical College at Westchester Medical Center, Valhalla, NY in Hematology/Oncology. He is also a member of the American Society of Hematology, American Society of Clinical Oncology, American Medical Association, American Society of Bone Marrow Transplantation (ASBMT) and was a member of cooperative cancer groups (Alliance, CTEP).
Evaluation and management of patients with hematologic and oncologic disorders with an emphasis on tailoring treatments for an individual patient (personalized medicine). I am also interested in using novel agents so as to reduce the toxicity without compromising on efficacy.
Jawaharlal Nehru Medical College, Belgaum, India, 2004
Internal Medicine - New York Medical College at Westchester Medical Center, Valhalla, NY, 2007
Internal Medicine - New York Medical College at Westchester Medical Center, Valhalla, NY, 2009
Hematology/Oncology - New York Medical College, Valhalla, NY, 2012
| Title: | Comparison of liposomal doxorubicin versus conventional anthracyclines: A meta-analysis. |
| Authors: | Rafiyath SM, Lamba G, Singh P, Rasul M and Liu D |
| Publisher: | Journal of Clinical Oncology |
| Date: | |
| Issue: | 28 (15_suppl), e13128 |
| Description: | (Meeting Abstracts) |
| Title: | Colonic perforation secondary to chronic lymphocytic leukemia infiltration without Richter transformation. |
| Authors: | Bitetto AM, Lamba G, Cadavid G, Shah D, Forlenza T, Rotatori F and Rafiyath SM |
| Publisher: | Leukemia & lymphoma |
| Date: | |
| Issue: | 52 (5), 930 |
| Description: |
| Title: | Malignant glomus tumor of kidney: the first reported case and review of literature |
| Authors: | Lamba G, Rafiyath SM, Kaur H, Khan S, Singh P, Hamilton AM and Ang DC |
| Publisher: | Human pathology |
| Date: | 2011 |
| Issue: | 42(8):1200-3 |
| Description: |
| Title: | Use of Conjugated Estrogens in Life-Threatening Gastrointestinal Bleeding in Hemodialysis Patients—A Review. |
| Authors: | Lamba G, Kaur H, Adapa S, Shah D, Malhotra B.K, Rafiyath S.M, Thakar K, Fernandez A.C. |
| Publisher: | Clinical and Applied Thrombosis/Hemostasis |
| Date: | 2012 Mar |
| Issue: | 12 PMID: 22411999 |
| Description: |
| Title: | Recent advances and novel agents for gastrointestinal stromal tumor (GIST) |
| Authors: | Lamba G, Ambrale S, Gupta R, Lee B, Rafiyath SM and Liu D. |
| Publisher: | Journal of Hematology & Oncology |
| Date: | |
| Issue: | 5 (1), 21 |
| Description: |
Accepted Health Plan information is only as accurate as the most current information submitted. Prior to your appointment, it is advisable to verify with a physician office that they are still a participating provider.